Latest News | Mankind to Set Up Committee to Evaluate Ways to Integrate BSV
Get latest articles and stories on Latest News at LatestLY. Mankind Pharma on Monday said its board has approved a proposal to constitute a committee to evaluate various structures to integrate Bharat Serums and Vaccines (BSV) with itself.
New Delhi, Apr 14 (PTI) Mankind Pharma on Monday said its board has approved a proposal to constitute a committee to evaluate various structures to integrate Bharat Serums and Vaccines (BSV) with itself.
The company's board has decided to consider and evaluate various structural alternatives to integrate BSV with itself, the drugmaker said in a regulatory filing.
Also Read | 8th Pay Commission: How Much Basic Salary Will Increase if Fitment Factor Raised to 2.86?.
A concrete plan for the proposed structural integration will be placed before the board for approval in the coming months after detailed consultation of the Structural Integration Committee with the financial, legal, tax and other advisors, it added.
This will be subject to all necessary shareholder, creditor and regulatory approvals, as may be applicable, the company said.
The company's board also approved the incorporation of a wholly-owned subsidiary, directly or indirectly, in Russia.
Last year in October, Mankind completed the Rs 13,768 crore deal to acquire BSV.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)